Marchini S - Search Results

1

Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts.

Todeschini P, Salviato E, Paracchini L, Ferracin M, Petrillo M, Zanotti L, Tognon G, Gambino A, Calura E, Caratti G, Martini P, Beltrame L, Maragoni L, Gallo D, Odicino FE, Sartori E, Scambia G, Negrini M, Ravaggi A, D'Incalci M, Marchini S, Bignotti E, Romualdi C. Todeschini P, et al. Among authors: marchini s. Cancer Lett. 2017 Mar 1;388:320-327. doi: 10.1016/j.canlet.2016.12.017. Epub 2016 Dec 22. Cancer Lett. 2017. PMID: 28017893

2

Sequence-specific DNA alkylation of novel tallimustine derivatives.

Marchini S, Cozzi P, Beria I, Geroni C, Capolongo L, D'Incalci M, Broggini M. Marchini S, et al. Anticancer Drug Des. 1998 Apr;13(3):193-205. Anticancer Drug Des. 1998. PMID: 9595033

3

Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.

Marchini S, Cirò M, Gallinari F, Geroni C, Cozzi P, D'Incalci M, Broggini M. Marchini S, et al. Br J Cancer. 1999 Jun;80(7):991-7. doi: 10.1038/sj.bjc.6690453. Br J Cancer. 1999. PMID: 10362106 Free PMC article.

4

Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents.

Colella G, Marchini S, D'Incalci M, Brown R, Broggini M. Colella G, et al. Among authors: marchini s. Br J Cancer. 1999 May;80(3-4):338-43. doi: 10.1038/sj.bjc.6690360. Br J Cancer. 1999. PMID: 10408835 Free PMC article.

5

Development of distamycin-related DNA binding anticancer drugs.

Marchini S, Broggini M, Sessa C, D'Incalci M. Marchini S, et al. Expert Opin Investig Drugs. 2001 Sep;10(9):1703-14. doi: 10.1517/13543784.10.9.1703. Expert Opin Investig Drugs. 2001. PMID: 11772279 Review.

6

Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.

Geroni C, Marchini S, Cozzi P, Galliera E, Ragg E, Colombo T, Battaglia R, Howard M, D'Incalci M, Broggini M. Geroni C, et al. Among authors: marchini s. Cancer Res. 2002 Apr 15;62(8):2332-6. Cancer Res. 2002. PMID: 11956092

7

Changes in gene expression profile induced by the anticancer agent Aplidine in Molt-4 leukemic cell lines.

Marchini S, Chiorino G, Faircloth GT, D'Incalci M. Marchini S, et al. J Biol Regul Homeost Agents. 2002 Jul-Sep;16(3):241-8. J Biol Regul Homeost Agents. 2002. PMID: 12456028

8

Effect of Aplidin in acute lymphoblastic leukaemia cells.

Erba E, Serafini M, Gaipa G, Tognon G, Marchini S, Celli N, Rotilio D, Broggini M, Jimeno J, Faircloth GT, Biondi A, D'Incalci M. Erba E, et al. Among authors: marchini s. Br J Cancer. 2003 Aug 18;89(4):763-73. doi: 10.1038/sj.bjc.6601130. Br J Cancer. 2003. PMID: 12915891 Free PMC article.

9

New molecules and strategies in the field of anticancer agents.

Marchini S, D'Incalci M, Broggini M. Marchini S, et al. Curr Med Chem Anticancer Agents. 2004 May;4(3):247-62. doi: 10.2174/1568011043352966. Curr Med Chem Anticancer Agents. 2004. PMID: 15134503 Review.

10

Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743.

Marchini S, Marrazzo E, Bonomi R, Chiorino G, Zaffaroni M, Weissbach L, Hornicek FJ, Broggini M, Faircloth GT, D'Incalci M. Marchini S, et al. Eur J Cancer. 2005 Jan;41(2):323-33. doi: 10.1016/j.ejca.2004.10.021. Eur J Cancer. 2005. PMID: 15661559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters